Excitement Among Proof-of-Concept Drug Companies Could Spill Over Into This Lesser-Known Name, page-6

This plan put forward by SSH for a Patient selection committee Is a big win for SSH, I have no doubt when the investigators see how well the patients implanted are doing compared to those on standard of care , as Bill Abraham said , it would be un ethical not to provide those in the control arm with a C-Pulse if those with C-Pulse are doing so well , the protocol allows for this , I have no doubt at some stage after 50 and 90 patients have been implanted show the excellent results seen to date , the control arm will be given a C-pulse and the trial halted. I think this will happen sooner than the market thinks.